Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation

Biochemical Journal

Volumn 386, Issue 2, 2005, Pages 341-348

  Steiner, Debora ^a   Avidor Reiss, Tomer ^a   Schallmach, Ester ^a   Butovsky, Elena ^a   Lev, Nirit ^a   Vogel, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Adenylate cyclase type VIII; CAMP; Dopamine receptor; G protein coupled receptor; Opiate receptor; Superactivation

Indexed keywords

ACTIVATION ANALYSIS; CELLS; ENZYME INHIBITION;

ADENYLATE CYCLASE (AC); MORPHINE; QUINPIROLE; SUPERACTIVATION;

ENZYMES;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TYPE VIII; ADENYLATE CYCLASE TYPE VIII A; ADENYLATE CYCLASE TYPE VIII B; ADENYLATE CYCLASE TYPE VIII C; CYCLIC AMP; CYCLIC AMP DERIVATIVE; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; QUINPIROLE; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ARTICLE; C1B DOMAIN; ENZYME ACTIVATION; ENZYME GLYCOSYLATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUPERACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN VARIANT; RECEPTOR UPREGULATION;

ADENYLATE CYCLASE; ALTERNATIVE SPLICING; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FORSKOLIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; IONOMYCIN; MORPHINE; PERTUSSIS TOXIN; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; TIME FACTORS; VARIATION (GENETICS);

EID: 14844303569     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041670     Document Type: Article

References (42)

1. Mons, N. and Cooper, D. M. (1995) Adenylatecyclases: critical foci in neuronal signaling. Trends Neurosci. 18, 536-542
2. Simonds, W. F. (1999) G protein regulation of adenylate cyclase. Trends Pharmacol. Sci. 20, 66-73
3. Sunahara, R. K. and Taussig, R. (2002) Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol. Interv. 2, 168-184
4. Avidor-Reiss, T., Nevo, I., Levy, R., Pfeuffer, T. and Vogel, Z. (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ. J. Biol. Chem. 271, 21309-21315
5. Avidor-Reiss, T., Nevo, I., Saya, D., Bayewitch M. and Vogel, Z. (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J. Biol. Chem. 272, 5040-5047
6. i-protein βγ subunits Nature (London) 356, 159-161
7. Nevo, I., Avidor-Reiss, T., Levy, R., Bayewitch, M., Heldman, E. and Vogel, Z. (1998) Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors. Mol. Pharmacol. 54, 419-426
8. Rhee, M. H., Bayewitch, M., Avidor-Reiss, T., Levy, R. and Vogel, Z. (1998) Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J. Neurochem. 71, 1525-1534
9. i/o-coupled receptors? Life Sci. 73, 2913-2925
10. 1 cannabinoid receptor. Mol. Pharmacol. 57, 746-752
11. Thomas, J. M. and Hoffman, B. B. (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol. Pharmacol. 49, 907-914
12. Watts, V. J. and Neve, K. A. (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol. Pharmacol. 50, 966-976
13. Childers, S. R. (1991) Opioid receptor-coupled second messenger systems. Life Sci. 48, 1991-2003
14. Nestler, E. J. and Aghajanian, G. K. (1997) Molecular and cellular basis of addiction. Science 278, 58-63
15. Sharma, S. K., Klee, W. A. and Nirenberg, M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 72, 3092-3096
16. Thomas, J. M. and Hoffman, B. B. (1987) Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol. Sci. 8, 308-311
17. Sabol, S. L. and Nirenberg, M. (1979) Regulation of adenylate cyclase of neuroblastoma × glioma hybrid cells by α-adrenergic receptors. II. Long lived increase of adenylate cyclase activity mediated by α receptors. J. Biol. Chem. 254, 1921-1926
18. Wilkening, D., Sabol, S. L. and Nirenberg, M. (1980) Control of opiate receptor-adenylate cyclase interactions by calcium ions and guanosine-5′- triphosphate. Brain Res. 189, 459-466
19. MacEwan, D. J., Kim, G. D. and Milligan, G. (1996) Agonist regulation of adenylate cyclase activity in neuroblastoma × glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the β2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity. Biochem. J. 318, 1033-1039
20. Rasmussen, K., Beitner-Johnson, O. B., Krystal, J. H., Aghajanian, G. K. and Nestler, E. J. (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological and biochemical correlates. J. Neurosci. 10, 2308-2317
21. Lane-Ladd, S. B., Pineda, J., Boundy, V. A., Pfeuffer, T., Krupinski, J., Aghajanian, G. K. and Nestler, E. J. (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 7890-7901
22. Matsuoka, I., Maldonado, R., Defer, N., Noel, F., Hanoune, J. and Roques, B. P. (1994) Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. 268, 215-221
23. Freeman, W. M., Brebner, K., Patel, K. M., Lynch, W. J., Roberts, D. C. and Vrana, K. E. (2002) Repeated cocaine self-administration causes multiple changes in rat frontal cortex gene expression. Neurochem. Res. 27, 1181-1192
24. Yamamoto, M., Pohli, S., Durany, N., Ozawa, H., Saito, T., Boissl, K. W., Zochling, R., Riederer, P., Boning, J. and Gotz, M. E. (2001) Increased levels of calcium-sensitive adenylyl cyclase subtypes in the limbic system of alcoholics: evidence for a specific role of cAMP signaling in the human addictive brain. Brain Res. 895, 233-237
25. 2+/calmodulin. J. Biol. Chem. 271, 1089-1095
26. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J. Biol. Chem. 269, 12190-12195
27. Cumbay, M. G. and Watts, V. J. (2004) Novel regulatory properties of human type 9 adenylate cyclase. J. Pharmacol. Exp. Ther. 310, 108-115
28. Wu, G. C., Lai, H. L., Lin, Y. W., Chu, Y. T. and Chern, Y. (2001) N-glycosylation and residues Asn805 and Asn890 are involved in the functional properties of type VI adenylyl cyclase. J. Biol. Chem. 276, 35450-35457
29. iα binding site on type V adenylyl cyclase. J. Biol. Chem. 273, 25831-25839
30. 3H]cAMP in cell monolayers, cell suspensions, and tissue slices. Methods Enzymol. 195, 22-28
31. Avidor-Reiss, T., Zippel, R., Levy, R., Saya, D., Ezra, V., Barg, J., Matus-Leibovitch, N. and Vogel, Z. (1995) κ-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Lett. 361, 70-74
32. Mollner, S. and Pfeuffer, T. (1991) Characteristics and use of monoclonal antibodies to various forms of adenylyl cyclase. Methods Enzymol. 195, 121-129
33. Avidor-Reiss, T., Bayewitch, M., Levy, R., Matus-Leibovitch, N., Nevo, I. and Vogel, Z. (1995) Adenylyl cyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270, 29732-29738
34. Levin, L. R. and Reed, R. R. (1995) Identification of functional domains of adenylyl cyclase using in vivo chimeras. J. Biol. Chem. 270, 7573-7579
35. 2+ of AC5 revealed by mutants and chimeric constructs. J. Biol. Chem. 277, 33139-33147
36. Scholich, K., Barbier, A. J., Mullenix, J. B. and Patel, T. B. (1997) Characterization of soluble forms of nonchimeric type V adenylyl cyclases. Proc. Natl. Acad. Sci. U.S.A. 94, 2915-2920
37. Gu, C. and Cooper, D. M. (1999) Calmodulin-binding sites on adenylyl cyclase type VIII. J. Biol. Chem. 274, 8012-8021
38. 2+-stimulated adenylyl cyclases by G-coupled receptors in vivo. J. Biol. Chem. 271, 33308-33316
39. oα selectively associate with the cloned somatostatin receptor subtype SSTR2. J. Biol. Chem. 268, 10721-10727
40. Nestler, E. J. (1997) Molecular mechanisms underlying opiate addiction: implication for medications development. Semin. Neurosci. 9, 84-93
41. Jones, S. B. and Bylund, D. B. (1988) Characterization and possible mechanisms of α2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cells. J. Biol. Chem. 263, 14236-14244
42. Palmer, T. M., Harris, C. A., Coote, J. and Stiles, G. L. (1997) Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor. Mol. Pharmacol. 52, 632-640